PlainPharmaWatch

CMS Open Payments · Program Year 2024

Salix Pharmaceuticals, a division of Bausch Health US, LLC

Salix Pharmaceuticals, a division of Bausch Health US, LLC reported $4,399,798.16 in payments to 161,040 physicians and teaching hospitals across 161,040 transactions.

See the rankings → How this is sourced
$4.4M
Total payments
161,040
Transactions
161,040
Recipients
−$740.1K
General Payments vs PY2023

Salix Pharmaceuticals, a division of Bausch Health US, LLC reported $4,399,798.16 in payments to 161,040 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #293 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $27.32 per recipient across 7 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Salix Pharmaceuticals, a division of Bausch Health US, LLC pairs top-quartile payment volume with an unusually diversified payment pattern across a wide recipient base.

#293
of 1,925 companies
0.0%
of all US industry payments
0.0%
paid to its single top recipient
7
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

Salix Pharmaceuticals, a division of Bausch Health US, LLC's CMS-reported General Payments decreased by $740.1K (−14.4%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: SALIX PHARMACEUTICALS, A DIVISION OF BAUSCH HEALTH US, LLCPY2023: SALIX PHARMACEUTICALS, A DIVISION OF BAUSCH HEALTH US, LLCPY2024: Salix Pharmaceuticals, a division of Bausch Health US, LLC. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$5.1MPY2024$4.4M
PY2023
$5,139,901.38
PY2024
$4,399,798.16

How Salix Pharmaceuticals, a division of Bausch Health US, LLC ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Salix Pharmaceuticals, a division of Bausch Health US, LLC's total vs. every reporting company

CMS Open Payments, Program Year 2024

$4,399,798 Top 15% higher than 85% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). Below this entry. $752,621–$2,337,813: 263 reporting companies (14%). Below this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). This entry sits in this band. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Salix Pharmaceuticals, a division of Bausch Health US, LLC

Salix Pharmaceuticals, a division of Bausch Health US, LLC ranks #293 out of 1,925 companies in the CMS Open Payments database for Program Year 2024, a comparatively small 0.0% slice of all industry payments reported nationwide for the year. The underlying total is $4,399,798.16 across 161,040 transactions to 161,040 physicians and teaching hospitals - $27.32 per transaction and $27.32 per recipient on average.

The 7-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Food and Beverage" at $2.8M, accounting for 64.4% of the company's reported total and 160,083 transactions.

General Payment Breakdown by Type

Across 7 types of general payments, Salix Pharmaceuticals, a division of Bausch Health US, LLC's largest category was "Food and Beverage" at $2.8M - 64.4% of the company's reported total.

How Salix Pharmaceuticals, a division of Bausch Health US, LLC divides its payments

Ranked by total dollars reported per category

1. Food and Beverage$2.8M2. Compensation for Faculty …$862.8K3. Consulting Fee$386.6K4. Travel and Lodging$145.2K5. Compensation for Services…$94.1K6. Grant$76.7K7. Education$201.89
Payment Type Amount Transactions
Food and Beverage $2.8M 160,083
Compensation for Faculty or Speaker (Medical Education) $862.8K 259
Consulting Fee $386.6K 75
Travel and Lodging $145.2K 556
Compensation for Services Other Than Consulting $94.1K 38
Grant $76.7K 12
Education $201.89 17

Recipient Concentration in General Payments

The five largest recipient relationships account for $409,119.06 (9.3%) of $4,399,798.16 in this company's General Payments records across 42,072 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Salix Pharmaceuticals, a division of Bausch Health US, LLC

The five named recipients with the highest reported General Payments from this company

Eileen M Almon$91.9KConar Fitton$88.6KArun Jesudian$82.9KApurva Modi$76.8KKristen Marie Lervik$68.9K
  1. 1

    Eileen M Almon

    $91,920.00 across 4 reported transactions

  2. 2

    Conar Fitton

    $88,563.37 across 120 reported transactions

  3. 3

    Arun Jesudian

    $82,886.63 across 95 reported transactions

  4. 4

    Apurva Modi

    $76,809.06 across 100 reported transactions

  5. 5

    Kristen Marie Lervik

    $68,940.00 across 3 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $27.32. Average per recipient: $27.32.

Total Amount

$4,399,798.16

Avg per Transaction

$27.32

Avg per Recipient

$27.32

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Salix Pharmaceuticals, a division of Bausch Health US, LLC Share

0.0%

#293 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Salix Pharmaceuticals, a division of Bausch Health US, LLC

Exact Sciences Corporation

$4.4M 107,493 recipients

Octapharma USA, Inc.

$4.4M 5,207 recipients

Bolton Medical Inc

$4.4M 4,442 recipients

Novocure Inc.

$4.5M 3,615 recipients

bluebird bio, Inc.

$4.5M 229 recipients

Kerecis Limited

$4.3M 26,463 recipients

Frequently Asked Questions

How much did Salix Pharmaceuticals, a division of Bausch Health US, LLC pay to physicians and hospitals in 2024? ▾
0.0% of all industry payments reported to CMS Open Payments for 2024 came from Salix Pharmaceuticals, a division of Bausch Health US, LLC, totaling $4,399,798.16 across 161,040 transactions to physicians and hospitals.
How many physicians received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC? ▾
161,040 physicians and teaching hospitals received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC in 2024, averaging $27.32 per recipient.
What types of payments did Salix Pharmaceuticals, a division of Bausch Health US, LLC make? ▾
Salix Pharmaceuticals, a division of Bausch Health US, LLC made 7 different types of general payments (consulting, meals, travel, and similar categories). The largest general-payment category was "Food and Beverage" at $2.8M, representing 64.4% of the company's reported total.
How does Salix Pharmaceuticals, a division of Bausch Health US, LLC rank among pharmaceutical companies? ▾
Out of 1,925 companies in the CMS Open Payments database for 2024, Salix Pharmaceuticals, a division of Bausch Health US, LLC ranks #293 by total payment amount.
What is the average payment size from Salix Pharmaceuticals, a division of Bausch Health US, LLC? ▾
The average transaction from Salix Pharmaceuticals, a division of Bausch Health US, LLC was $27.32 in 2024. The company made 161,040 total transactions to 161,040 recipients.
Where does the payment data for Salix Pharmaceuticals, a division of Bausch Health US, LLC come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Salix Pharmaceuticals, a division of Bausch Health US, LLC's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.